Henschke Claudia I, Boffetta Paolo, Yankelevitz David F, Altorki Nasser
Department of Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.
Department of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.
Thorac Surg Clin. 2015 May;25(2):129-43. doi: 10.1016/j.thorsurg.2014.12.001.
The International Early Lung Cancer Action Program (I-ELCAP) used a novel study design that provided quantitative information about annual CT screening for lung cancer. The results stimulated additional studies of lung cancer screening and ultimately led to the National Lung Screening Trial (NLST) being initiated in 2002, as the initial report in 1999 was sufficiently compelling to reawaken interest in screening for lung cancer. The authors think that the I-ELCAP and NLST "story" provides a strong argument for relevant agencies to consider alternative study designs for the public funding of studies aimed at evaluating the effectiveness of screening and other medical trials.
国际早期肺癌行动计划(I-ELCAP)采用了一种新颖的研究设计,该设计提供了有关肺癌年度CT筛查的定量信息。这些结果激发了对肺癌筛查的更多研究,并最终促成了2002年启动的国家肺癌筛查试验(NLST),因为1999年的初步报告极具说服力,足以重新唤起人们对肺癌筛查的兴趣。作者认为,I-ELCAP和NLST的“故事”有力地证明了相关机构应考虑采用替代研究设计,以便为旨在评估筛查及其他医学试验有效性的研究提供公共资金。